Drug Study Erythhropoietin

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 1

 Brand Name: _ Epogen _ Generic Name: Erythropoietin Drug Classification: Therapeutic: 

antianemics Pharmacologic:
hormones

Dosage, Route & Frequency Side Effects/


Drug-Drug &
Adverse
Drug Action Drug-Food Indications Contraindications
Recommended Prescribed Reactions (By
Interactions
System)

NONE Stimulates Drug: No Anemia Contraindicated in CNS: Seizures,


erythropoiesis clinically associated with patients with: headache. CV:
Patients with CKD on
(production of red significant chronic renal Congestive
dialysis
blood interactions failure. Anemia Heart Failure,
 Initiate cells). Therapeutic established. secondary to  Poorly controlled myocardial
treatment Effects: Maintains zidovudine (AZT) blood pressure. infarction,
when and may elevate therapy in HIV- Sickle cell disease. stroke,
hemoglobin RBCs, decreasing infected hypertension
the need for patients. Anemia  Ischemic vascular
(Hgb) level <10
disease. Derm:
g/dL transfusions. from
transient
chemotherapy in  Thrombocytosis.
 If Hgb level rashes. Endo:
patients with
approaches or  Epilepsy. restored
nonmyeloid
>11 g/dL, fertility,
malignancies.
reduce or  Malignant disease. resumption of
Reduction of
interrupt dose Chronic liver menses.
need for
failure.
 50-100 transfusions Misc: increase
units/kg IV/SC after surgery  Cardiovascular mortality and
3 times weekly disease. increase tumor
initially growth (with
 Breastfeeding
hemoglobin
≥12 g/dL).

You might also like